非富血供胰腺神经内分泌肿瘤与胰腺导管腺癌的MR鉴别诊断:回顾性横断面研究
回顾性纳入手术证实的74例胰腺神经内分泌肿瘤(PNET)和82例胰腺导管腺癌(PDAC)患者,评估钆布醇增强MR形态学与强化方式。非富血供PNET中边界清晰和门静脉期高/等强化出现率显著高于PDAC,两者联合鉴别敏感度64%、特异度99%。
要点
- 边界清晰和门静脉期高/等强化是非富血供PNET与PDAC鉴别的独立特征(OR分别为20.3和16.1)。
- 联合边界清晰与门静脉期高/等强化标准,鉴别PNET与PDAC的敏感度为64%、特异度为99%。
- 非富血供PNET中最大上游实质厚度≥10 mm更常见,而胰管扩张、血管侵犯和胰周浸润更少见。
核心结论
- 边界清晰和门静脉期高/等强化是更常见于非富血供PNET的有用MR特征,可能有助于将其与PDAC鉴别。
研究设计与样本
- 回顾性横断面研究,纳入手术证实的74例PNET和82例PDAC患者,均行钆布醇增强MR检查,由两名放射科医师独立评估形态学和时间强化模式,并进行定量分析。
关键影像表现/征象
- 非富血供PNET表现为边界清晰、门静脉期高/等强化及最大上游实质厚度≥10 mm的频率显著高于PDAC(P < .05)。
- 非富血供PNET出现胰管扩张、血管侵犯和胰周浸润的频率显著低于PDAC(P < .05)。
诊断标准与关键数值
- 多因素分析显示边界清晰和门静脉期高/等强化为独立鉴别特征,OR分别为20.3和16.1。
- 应用边界清晰联合门静脉期高/等强化标准,鉴别PNET与PDAC的敏感度为64%、特异度为99%。
临床应用与阅片要点
- 阅片时注意评估肿瘤边界及门静脉期强化程度,非富血供PNET更常见边界清晰和门静脉期高/等强化。
- 非富血供PNET中最大上游实质厚度≥10 mm更常见,而胰管扩张、血管侵犯和胰周浸润更少见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine useful magnetic resonance (MR) imaging features to differentiate nonhypervascular pancreatic neuroendocrine tumors (PNETs) from pancreatic ductal adenocarcinomas (PDACs). Materials and Methods The institutional review board approved this retrospective study and waived the informed consent requirement. Seventy-four patients with surgically confirmed PNETs and 82 patients with PDACs who underwent gadobutrol-enhanced MR imaging were included. Two radiologists independently evaluated the morphologic characteristics and temporal enhancement patterns of each tumor. Quantitative analysis, including measurement of tumor size, maximal upstream parenchymal thickness (MUPT), contrast-to-noise ratio, and apparent diffusion coefficient values, was performed. Uni- and multivariate logistic regression analyses were performed to identify relevant features to differentiate between PNETs and PDACs. Results On the basis of arterial enhancement, 38 PNETs (51%, 38 of 74) were hypervascular and 36 PNETs (49%, 36 of 74) were nonhypervascular. At MR imaging, nonhypervascular PNETs showed significantly higher frequencies of a well-defined margin, portal hyper- or isoenhancement, and MUPT of 10 mm or greater but lower frequencies of ductal dilatation, vascular invasion, and peripancreatic infiltration when compared with PDACs (P < .05 for all). At multivariate analysis, a well-defined margin and portal hyper- or isoenhancement were independent significant differentiators of PNETs from PDACs (odds ratio, 20.3 and 16.1, respectively). When applying the criteria of a well-defined margin and portal hyper- or isoenhancement, 64% of sensitivity and 99% of specificity were observed for the differential diagnosis of PNETs from PDACs. Conclusion A well-defined margin and hyper- or isoenhancement in the portal venous phase are useful MR imaging features that are more common in nonhypervascular PNETs and may help discriminate nonhypervascular PNETs from PDACs. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Jeon SK, Lee JM, Joo I, et al. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study. Radiology. 2017. PMID: 28092495. doi:10.1148/radiol.2016160586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。